BOSTON, April 22, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology ... treatment of relapsed or refractory aggressive B-cell NHL was made available as part of the 65th ASH ...

Serie B, il Bari cambia ancora allenatore: esonerato Iachini, subentrato a Marino e promosso Giampaolo dalla Primavera Nuovo cambio in panchina per il Bari: la dirigenza... Il Modena ha ...

REDWOOD CITY, Calif. & BOSTON - Adicet Bio, Inc. (NASDAQ:ACET), a biotechnology company focusing on the development of gamma delta T cell therapies, announced today that its ...

BOSTON, May 14, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology ... treatment of relapsed or refractory aggressive B-cell NHL was made available as part of the 65th ASH ...

Is Adicet Bio, Inc. (ACET) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Adicet Bio, Inc. is a member of the Medical sector.

The average one-year price target for Adicet Bio (NASDAQ:ACET) has been revised to 24.48 / share.This is an decrease of 12.90% from the prior estimate of 28.11 dated June 1, 2023. The price target ...